Publikationen, an denen er mitarbeitet URKO AGUIRRE LARRAKOETXEA (29)

2023

  1. Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections

    Journal of Laboratory and Precision Medicine, Vol. 8

2022

  1. Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study

    Revista Clinica Espanola, Vol. 222, Núm. 1, pp. 22-30

  2. Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 58, Núm. 12, pp. 802-808

2021

  1. Checking Siblings of Patients with Idiopathic Pulmonary Fibrosis as a Scheme for Early Disease Detection

    Annals of the American Thoracic Society

  2. Predictors of mortality of COVID-19 in the general population and nursing homes

    Internal and Emergency Medicine, Vol. 16, Núm. 6, pp. 1487-1496

2019

  1. A computer application to predict adverse events in the short-term evolution of patients with exacerbation of chronic obstructive pulmonary disease

    JMIR Medical Informatics, Vol. 7, Núm. 2

2018

  1. Predicting 1-year mortality after hospitalization for community-Acquired pneumonia

    PLoS ONE, Vol. 13, Núm. 2

2016

  1. Determinants of change in physical activity during moderate-to-severe copd exacerbation

    International Journal of COPD, Vol. 11, pp. 251-261

  2. Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients

    International Journal of COPD, Vol. 11, Núm. 1, pp. 2919-2930

2015

  1. Assessment of the Performance of Imputation Techniques in Observational Studies with Two Measurements

    International Journal of Statistics in Medical Research, Vol. 4, Núm. 3, pp. 240-251

  2. Cribado de la tuberculosis en inmigrantes adolescentes indocumentados usando el QuantiFERON®-TB Gold In-Tube

    Medicina Clinica, Vol. 145, Núm. 1, pp. 7-13

2014

  1. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

  2. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments

    BMC Medicine, Vol. 12, Núm. 1

  3. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation

    Respiration, Vol. 88, Núm. 4, pp. 298-306

2013

  1. Análisis de la discordancia entre la prueba de la tuberculina y el QuantiFERON-TB® Gold In-Tube en estudios de contactos

    Medicina Clinica, Vol. 140, Núm. 7, pp. 289-295

  2. Predictors of hospital admission in exacerbations of chronic obstructive pulmonary disease

    International Journal of Tuberculosis and Lung Disease, Vol. 17, Núm. 12

  3. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Impact of anxiety and depression on disease control and quality of life in asthma patients

    Journal of Asthma, Vol. 49, Núm. 2, pp. 201-208

  3. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745